Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges

Abstract excerpt

Idiosyncratic drug-induced liver injury (IDILI) remains a significant problem for patients and drug development. The idiosyncratic nature of IDILI makes mechanistic studies difficult, and little is known of its pathogenesis for certain. Circumstantial evidence suggests that most, but not all, IDILI is caused by reactive metabolites of drugs that are bioactivated by cytochromes P450 and other enzymes in the liver....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug-Induced Hepatotoxicity and Protection
• Share to Drug Transport and Resistance Mechanisms
• Share to Pharmacogenetics and Drug Metabolism